BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11227494)

  • 1. PR-000350, a novel hypoxic radiosensitizer, enhances tumor cell killing by promoting apoptosis preferentially in the S-phase fraction.
    Kuno Y; Shinomiya N
    Apoptosis; 2000 Feb; 5(1):69-77. PubMed ID: 11227494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo study of radiosensitizing effect of hypoxic cell radiosensitizer PR-350 on a human small cell lung cancer.
    Suzuki Y; Hasegawa M; Hayakawa K; Mitsuhashi N; Niibe H
    Anticancer Res; 1999; 19(5B):3993-4000. PubMed ID: 10628343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia.
    Mizumoto K; Qian LW; Zhang L; Nagai E; Kura S; Tanaka M
    J Radiat Res; 2002 Mar; 43(1):43-51. PubMed ID: 12056329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis-diamminedichloroplatinum induces a block in G2/M.
    Shinomiya N; Takemura T; Iwamoto K; Rokutanda M
    Cytometry; 1997 Apr; 27(4):365-73. PubMed ID: 9098629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
    Grégoire V; Van NT; Stephens LC; Brock WA; Milas L; Plunkett W; Hittelman WN
    Cancer Res; 1994 Dec; 54(23):6201-9. PubMed ID: 7954467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a hypoxic cell sensitizer doranidazole on the radiation-induced apoptosis of mouse L5178Y lymphoma cells.
    Aoki M; Furusawa Y; Shibamoto Y; Kobayashi A; Tsujitani M
    J Radiat Res; 2002 Jun; 43(2):161-6. PubMed ID: 12238330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different mechanisms between premitotic apoptosis and postmitotic apoptosis in X-irradiated U937 cells.
    Shinomiya N; Kuno Y; Yamamoto F; Fukasawa M; Okumura A; Uefuji M; Rokutanda M
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):767-77. PubMed ID: 10837963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
    Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X
    Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-irradiation hypoxic incubation of X-irradiated MOLT-4 cells reduces apoptotic cell death by changing the intracellular redox state and modulating SAPK/JNK pathways.
    Hamasu T; Inanami O; Tsujitani M; Yokoyama K; Takahashi E; Kashiwakura I; Kuwabara M
    Apoptosis; 2005 May; 10(3):557-67. PubMed ID: 15909118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and etanidazole alter radiation-induced apoptosis in HL60 cells but not in MOLT-4 cells.
    Inanami O; Sugihara K; Okui T; Hayashi M; Tsujitani M; Kuwabara M
    Int J Radiat Biol; 2002 Apr; 78(4):267-74. PubMed ID: 12020438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIF-1alpha by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo.
    Yasui H; Ogura A; Asanuma T; Matsuda A; Kashiwakura I; Kuwabara M; Inanami O
    Br J Cancer; 2008 Nov; 99(9):1442-52. PubMed ID: 18854835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Hypoxia on Radiosensitization of Cancer Cells by 5-Bromo-2'-deoxyuridine.
    Zdrowowicz M; Spisz P; Hać A; Herman-Antosiewicz A; Rak J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
    Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
    Gorodetsky R; Levdansky L; Ringel I; Vexler A
    Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines.
    Zölzer F; Streffer C
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):910-20. PubMed ID: 12377345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole.
    Shibamoto Y; Kubota T; Kishii K; Tsujitani M
    Radiother Oncol; 2000 Aug; 56(2):265-70. PubMed ID: 10927148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV scintillating particles as radiosensitizer enhance cell killing after X-ray excitation.
    Müller M; Wang Y; Squillante MR; Held KD; Anderson RR; Purschke M
    Radiother Oncol; 2018 Dec; 129(3):589-594. PubMed ID: 30539764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-chemical properties of the hypoxic cell radiosensitizer doranidazole (PR-350).
    Kuwabara M; Iida Y; Inanami O; Sawamura S; Yokoyama K; Tsujitani M
    J Radiat Res; 2002 Mar; 43(1):77-88. PubMed ID: 12056332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1α.
    Okuno T; Kawai K; Hata K; Murono K; Emoto S; Kaneko M; Sasaki K; Nishikawa T; Tanaka T; Nozawa H
    Anticancer Res; 2018 Jun; 38(6):3323-3331. PubMed ID: 29848680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.